Healthcare provider profile · identity verified

Albert D Agomaa, M.D.

Family Practice · NORTHAMPTON, MA · NPI 1104076793

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	568	155
Losartan Potassium	Losartan Potassium	350	101
Oxycodone Hcl	Oxycodone Hcl	292	63
Gabapentin	Gabapentin	289	74
Amlodipine Besylate	Amlodipine Besylate	283	78
Lisinopril	Lisinopril	249	67
Levothyroxine Sodium	Levothyroxine Sodium	241	63
Omeprazole	Omeprazole	206	60
Metoprolol Succinate	Metoprolol Succinate	200	49
Tamsulosin Hcl	Tamsulosin Hcl	175	50
Eliquis	Apixaban	173	34
Metformin Hcl Er	Metformin Hcl	170	51
Hydrochlorothiazide	Hydrochlorothiazide	162	47
Simvastatin	Simvastatin	140	36
Albuterol Sulfate Hfa	Albuterol Sulfate	139	53
Clonazepam	Clonazepam	139	25
Lorazepam	Lorazepam	130	43
Ozempic	Semaglutide	127	18
Trazodone Hcl	Trazodone Hcl	118	36
Metformin Hcl	Metformin Hcl	113	29
Allopurinol	Allopurinol	110	31
Sertraline Hcl	Sertraline Hcl	102	30
Zolpidem Tartrate	Zolpidem Tartrate	102	15
Pantoprazole Sodium	Pantoprazole Sodium	99	29
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	88	20
Tramadol Hcl	Tramadol Hcl	83	28
Montelukast Sodium	Montelukast Sodium	81	24
Furosemide	Furosemide	78	31
Prednisone	Prednisone	73	61
Fluoxetine Hcl	Fluoxetine Hcl	71	18
Fluticasone Propionate	Fluticasone Propionate	65	23
Mirtazapine	Mirtazapine	64	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	63	suppressed
Jardiance	Empagliflozin	62	17
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	61	13
Famotidine	Famotidine	61	17
Rosuvastatin Calcium	Rosuvastatin Calcium	61	19
Metoprolol Tartrate	Metoprolol Tartrate	58	18
Pregabalin	Pregabalin	57	15
Chlorthalidone	Chlorthalidone	53	19
Finasteride	Finasteride	53	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	50	22
Carvedilol	Carvedilol	49	12
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	49	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	49	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	48	39
Spironolactone	Spironolactone	48	15
Duloxetine Hcl	Duloxetine Hcl	47	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	46	14
Citalopram Hbr	Citalopram Hydrobromide	45	12
Bupropion Xl	Bupropion Hcl	44	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	13
Glipizide Er	Glipizide	42	13
Atenolol	Atenolol	41	13
Triamcinolone Acetonide	Triamcinolone Acetonide	36	22
Amitriptyline Hcl	Amitriptyline Hcl	35	11
Pravastatin Sodium	Pravastatin Sodium	33	11
Clopidogrel	Clopidogrel Bisulfate	32	11
Meloxicam	Meloxicam	32	suppressed
Tizanidine Hcl	Tizanidine Hcl	32	13
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Irbesartan	Irbesartan	29	suppressed
Potassium Chloride	Potassium Chloride	29	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	28	11
Glipizide	Glipizide	27	suppressed
Ipratropium Bromide	Ipratropium Bromide	25	20
Methadone Hcl	Methadone Hcl	25	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	25	suppressed
Morphine Sulfate Er	Morphine Sulfate	24	suppressed
Valsartan	Valsartan	23	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Methylphenidate Er	Methylphenidate Hcl	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	22	suppressed
Bupropion Hcl	Bupropion Hcl	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Diazepam	Diazepam	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Lamotrigine	Lamotrigine	21	suppressed
Novolog Flexpen	Insulin Aspart	20	suppressed
Sucralfate	Sucralfate	20	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	19
Ezetimibe	Ezetimibe	19	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Arnuity Ellipta	Fluticasone Furoate	18	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Torsemide	Torsemide	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Cephalexin	Cephalexin	17	15
Glimepiride	Glimepiride	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Oxycontin	Oxycodone Hcl	17	suppressed
Cilostazol	Cilostazol	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Morphine Sulfate	Morphine Sulfate	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Azithromycin	Azithromycin	15	14
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	15	suppressed
Liothyronine Sodium	Liothyronine Sodium	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	11
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	14	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Incruse Ellipta	Umeclidinium Bromide	14	suppressed
Nystatin	Nystatin	14	11
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Xifaxan	Rifaximin	14	suppressed
Creon	Lipase/Protease/Amylase	13	suppressed
Fluconazole	Fluconazole	13	11
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Levocarnitine	Levocarnitine	13	suppressed
Primidone	Primidone	13	suppressed
Tiadylt Er	Diltiazem Hcl	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Ambien	Zolpidem Tartrate	12	suppressed
Dextroamphetamine Sulfate	Dextroamphetamine Sulfate	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Flovent Hfa	Fluticasone Propionate	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Naproxen	Naproxen	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error